What is the clinical significance of mildly elevated hematocrit, RDW (Red Cell Distribution Width), lymphocytes, and eosinophils in a CBC (Complete Blood Count) with differential/platelet count?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Significance of Mildly Elevated Hematocrit, RDW, Lymphocytes, and Eosinophils in CBC

The mildly elevated hematocrit, lymphocytes, and eosinophils in this CBC suggest possible underlying conditions including early polycythemia vera, allergic reaction, or parasitic infection, requiring further evaluation based on clinical presentation.

Analysis of Abnormal CBC Parameters

Elevated Hematocrit (47.6%, H)

  • Hematocrit is mildly elevated above the reference range (34.0-46.6%)
  • This elevation should be interpreted in context with other RBC parameters:
    • Normal hemoglobin (14.8 g/dL)
    • Low MCHC (31.1 g/dL, L) - indicates decreased hemoglobin concentration within RBCs
    • Normal RBC count (5.07 x10E6/uL)
    • Normal MCV (94 fL)

Elevated Lymphocytes (3.9 x10E3/uL, H)

  • Absolute lymphocyte count is elevated above reference range (0.7-3.1 x10E3/uL)
  • Relative lymphocyte percentage (38%) is within expected range

Elevated Eosinophils (0.8 x10E3/uL, H)

  • Absolute eosinophil count is elevated above reference range (0.0-0.4 x10E3/uL)
  • Relative eosinophil percentage (7%) is elevated

Normal RDW (13.7%)

  • Despite being mentioned in the question, RDW is actually within normal limits (11.7-15.4%)
  • This indicates relatively uniform red cell size distribution

Differential Diagnosis

1. Early Polycythemia Vera (PV)

  • Elevated hematocrit is a cardinal feature of PV 1
  • According to Mayo Clinic guidelines, PV should be considered when:
    • Hemoglobin/hematocrit is higher than the 95th percentile of normal distribution
    • There is a documented increase above baseline for an individual patient
    • PV-related features accompany borderline-high hematocrit 1
  • The normal RDW and absence of marked elevation in other cell lines makes this less likely to be advanced PV

2. Allergic Reaction/Atopic Disorder

  • Elevated eosinophils (eosinophilia) is classically associated with allergic disorders
  • The combination of elevated lymphocytes and eosinophils is consistent with an allergic or hypersensitivity reaction 2
  • American Thoracic Society guidelines note that eosinophilia >1% in bronchoalveolar lavage can be seen in various allergic conditions 1

3. Parasitic Infection

  • Elevated eosinophil count may indicate a parasitic infection with a tissue phase 1
  • The Infectious Diseases Society of America notes that an increased eosinophil count may occur with parasitic infections 1

4. Early Chronic Myeloid Disorders

  • European LeukemiaNet guidelines recognize basophilia and eosinophilia as features of chronic myeloid disorders 1
  • However, this patient's basophil count is normal (0.1 x10E3/uL)
  • The absence of other features like splenomegaly or marked leukocytosis makes this less likely

5. Relative Polycythemia (Dehydration)

  • Hemoconcentration due to dehydration can cause elevated hematocrit
  • However, this typically affects all cell lines equally

Recommended Evaluation

  1. Clinical History Assessment:

    • Assess for symptoms of hyperviscosity (headache, blurred vision, dizziness)
    • Evaluate for allergic symptoms (pruritus, rash, respiratory symptoms)
    • Screen for risk factors for polycythemia (smoking, high altitude residence)
    • Inquire about travel history for possible parasitic exposure
    • Review medication history for drugs that may cause eosinophilia
  2. Laboratory Testing:

    • Serum erythropoietin level - to evaluate for PV (will be low in PV) 1
    • Iron studies - to assess for iron deficiency which may mask PV
    • Stool examination for ova and parasites if parasitic infection is suspected 1
    • IgE levels - if allergic disorder is suspected
    • Repeat CBC in 2-3 months to monitor trends 2
  3. Additional Testing Based on Clinical Suspicion:

    • If PV is strongly suspected: JAK2 V617F mutation testing
    • If allergic disorder is suspected: specific allergen testing
    • If respiratory symptoms are present: pulmonary function testing

Clinical Implications and Management

  • For mild elevations without symptoms, observation with repeat CBC in 2-3 months is appropriate 2
  • If hematocrit continues to rise or symptoms develop:
    • For suspected PV: refer to hematology for consideration of phlebotomy if hematocrit >45% 1
    • For eosinophilia related to allergic disorders: identify and treat the underlying cause
    • For parasitic infections: appropriate antiparasitic therapy

Pitfalls and Caveats

  • Isolated hematocrit elevation with normal hemoglobin may represent a laboratory error or sample processing issue
  • Low MCHC with normal MCV may indicate early iron deficiency, which can mask more significant polycythemia
  • Transient elevations in lymphocytes and eosinophils can occur with viral infections or stress responses
  • Recent COVID-19 infection or vaccination may affect CBC parameters 3
  • Altitude and smoking status can affect hematocrit levels and should be considered in interpretation

The pattern of abnormalities in this CBC requires clinical correlation and may warrant follow-up testing to determine the underlying cause and appropriate management strategy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation and Management of Abnormal Complete Blood Count (CBC) Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.